BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stockwell SR, Scott DE, Fischer G, et al. (2024) Selective Aurora A-TPX2 Interaction Inhibitors Have Efficacy as Targeted Antimitotic Agents. Journal of Medicinal Chemistry |
| Mortensen KT, Wong DSY, King TA, et al. (2023) Synthesis of sp-rich heterocyclic frameworks by a divergent synthesis strategy. Organic & Biomolecular Chemistry |
| Seki H, Walsh SJ, Bargh JD, et al. (2021) Rapid and robust cysteine bioconjugation with vinylheteroarenes. Chemical Science. 12: 9060-9068 |
| Iegre J, Atkinson EL, Brear PD, et al. (2021) Chemical probes targeting the kinase CK2: a journey outside the catalytic box. Organic & Biomolecular Chemistry. 19: 4380-4396 |
| Kidd SL, Fowler E, Reinhardt T, et al. (2020) Demonstration of the utility of DOS-derived fragment libraries for rapid hit derivatisation in a multidirectional fashion. Chemical Science. 11: 10792-10801 |
| Charoenpattarapreeda J, Walsh SJ, Carroll JS, et al. (2020) Expeditious Total Synthesis of Hemiasterlin via a Convergent Multi-component Strategy and Its Use in Targeted Cancer Therapeutics. Angewandte Chemie (International Ed. in English) |
| Stewart HL, Hanby AR, King TA, et al. (2020) An efficient, stereocontrolled and versatile synthetic route to bicyclic partially saturated privileged scaffolds. Chemical Communications (Cambridge, England) |
| Freudenreich J, Bartlett S, Kidd S, et al. (2020) Divergent synthesis of novel cylindrocyclophanes that inhibit methicillin-resistant Staphylococcus aureus (MRSA). Chemmedchem |
| Huggins DJ, Hardwick BS, Sharma P, et al. (2020) Development of a Novel Cell-Permeable Protein-Protein Interaction Inhibitor for the Polo-box Domain of Polo-like Kinase 1. Acs Omega. 5: 822-831 |
| Pettigrew TR, Porter RJ, Walsh SJ, et al. (2020) Total synthesis and biological evaluation of simplified aplyronine analogues as synthetically tractable anticancer agents. Chemical Communications (Cambridge, England) |